Informations générales (source: ClinicalTrials.gov)
Interest of Auriculotherapy in the Treatment of Xerostomia. (AURICULOXERO)
Interventional
N/A
Hopital Foch (Voir sur ClinicalTrials)
décembre 2019
décembre 2025
05 avril 2025
The aim of the study is to show that auriculotherapy is effective in the treatment of
xerostomia
Etablissements
| Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| GH PARIS SITE SAINT JOSEPH | David EBBO, MD | Contact (sur clinicalTrials) | |||
| HOPITAL FOCH | Mireille MICHEL-CHERQUI, MD | Contact (sur clinicalTrials) | |||
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| Hôpital Forcilles - 77150 - Férolles-Attilly - France | David GUIGOU, MD | Contact (sur clinicalTrials) | |||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| Centre Hospitalier Régional Universitaire de Brest - Hôpital Morvan - 29600 - Brest - Bretagne - France | Coralie Clodic, MD | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Patients over 18 years old;
- Complain about xerostomia after cervical irradiation in the context of ENT cancer;
- End of radiotherapy> 3 months
- Covered by a national healthcare insurance
- Consent form signed.
Non inclusion Criteria:
- Pregnant or breastfeeding women;
- Local counterindication to auriculotherapy;
- With anticoagulant treatment;
- History or existing of hemophilia;
- Valvular prosthesis;
- Ear's pavilion infection;
- Treatment by auriculotherapy or acupuncture in this indication in the previous 12
months;
- Having started in the 48 hours preceding the first auriculotherapy session, any new
management of xerostomia and likely to interfere with the study (specific medication
and/or complementary therapeutic management);
- Difficulty to comply with the treatment, questionnaires or study protocol;
- Being deprived of liberty or under guardianship.
- Patients over 18 years old;
- Complain about xerostomia after cervical irradiation in the context of ENT cancer;
- End of radiotherapy> 3 months
- Covered by a national healthcare insurance
- Consent form signed.
Non inclusion Criteria:
- Pregnant or breastfeeding women;
- Local counterindication to auriculotherapy;
- With anticoagulant treatment;
- History or existing of hemophilia;
- Valvular prosthesis;
- Ear's pavilion infection;
- Treatment by auriculotherapy or acupuncture in this indication in the previous 12
months;
- Having started in the 48 hours preceding the first auriculotherapy session, any new
management of xerostomia and likely to interfere with the study (specific medication
and/or complementary therapeutic management);
- Difficulty to comply with the treatment, questionnaires or study protocol;
- Being deprived of liberty or under guardianship.